ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

S Gesk; R D Gascoyne; B Schnitzer; N Bakshi; D Janssen; W Klapper; J I Martín-Subero; R Parwaresch; R Siebert

首页> 外文期刊>Leukemia >ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

【24h】

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

机译：ALK-Clathrin融合的ALK阳性弥漫性大B细胞淋巴瘤属于小儿淋巴瘤谱

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2005年第10期|共2页
作者
S Gesk; R D Gascoyne; B Schnitzer; N Bakshi; D Janssen; W Klapper; J I Martín-Subero; R Parwaresch; R Siebert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion. [J] . Momose S, Tamaru J, Kishi H, Human Pathology . 2009,第1期

机译：结合网格蛋白-ALK融合的ALK阳性弥漫性大B细胞淋巴瘤中的STAT3超活化。
2. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases [J] . Gabriela Gualco, Yasodha Natkunam, Carlos E Bacchi Modern Pathology . 2012,第5期

机译：B细胞淋巴瘤的频谱，无法分类，其特征介于弥漫性大B细胞淋巴瘤和经典霍奇金淋巴瘤之间：描述10例
3. Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases [J] . Annals of laboratory medicine. . 2015,第2期

机译：小儿B细胞淋巴瘤，无法分类，具有弥漫性大B细胞淋巴瘤和伯基特淋巴瘤之间的中间特征：两例报告
4. CHARACTERIZING CANINE LYMPHOMA AS A POTENTIAL LARGE ANIMAL MODEL OF HUMAN DIFFUSE LARGE B-CELL LYMPHOMA [C] . Kristy Richards, Alison Motsinger-Reif, Dahlia Nielsen, Annual Conference of the Veterinary Cancer Society . 2009

机译：将犬淋巴瘤表征为人弥漫性大型B细胞淋巴瘤的潜在大型动物模型
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation [O] . Hyekyung Lee, Hyunbin Shin, Nae Yu Kim, 2019

机译：回肠新膀胱内弥漫性大B细胞淋巴瘤的形成：与慢性炎症相关的弥散性大B细胞淋巴瘤的扩大范围。
7. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas [O] . Eugenia Haralambieva, Karen A. F. Pulford, Laurence Lamant, 2000

机译：B细胞表型的促进性大细胞淋巴瘤是一种促进淋巴瘤激酶（ALK）阴性，属于弥漫性大B细胞淋巴瘤的光谱

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

著录项

相似文献

相关主题

期刊订阅